Clinical trial Recruiting at 7 sites Interventional Ages 22 and up

Comparing two shoulder replacement systems for joint pain relief

Official title: A Randomized, Multi-Center, Prospective, Safety and Efficacy Study Comparing the Outcome of Total Reverse Shoulder Arthroplasty (RSA) With SMR Stemless Reverse vs SMR Reverse Shoulder System

Run by Limacorporate S.p.a · NCT04697004 · Data updated 2026-11-12

This study is testing a new shoulder replacement system to see if it can relieve pain and improve shoulder function just as well as the traditional system for people with shoulder issues.

Quick facts

Study typeInterventional
Ages22 Years and up
SexAll
Enrollment200 (estimated)
SponsorLimacorporate S.p.a
Industry-sponsored
Locations13 sites (Los Angeles, California and 12 other locations)
StatusRecruiting
StartedApril 1, 2021
Main results expectedDecember 30, 2028
Study endsDecember 30, 2028
Registry record updatedOctober 28, 2026
Trial IDNCT04697004 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 22 and older with severe shoulder joint dysfunction due to conditions like rotator cuff tears or severe osteoarthritis.

Probably not a fit

Patients with a BMI over 40 kg/m2 or those who have had recent shoulder surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of the SMR Stemless Reverse shoulder replacement system against the traditional SMR Reverse Shoulder System. It is a prospective, multi-center, randomized, controlled trial designed to demonstrate that the new stemless system is not inferior to the established system in terms of pain relief and restoration of shoulder function. Eligible patients will be randomized into one of the two groups after meeting specific inclusion criteria and signing an informed consent form. The trial is expected to enroll participants over a period of 24 months.

Why it matters

Potential benefit: If successful, this study could provide patients with a less invasive shoulder replacement option that offers similar or improved outcomes.

How similar studies have gone: Other studies have shown promising results with similar shoulder replacement approaches, indicating potential for success in this trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 22 years of age
2. Skeletally mature as evident by scapula and proximal humerus closure
3. Candidate for primary total shoulder replacement in a grossly rotator cuff deficient joint with severe arthropathy (disabled shoulder), when clinical indications based on physical exam and medical history including one or more of the following:

   1. Arthritis with rotator cuff tear not reparable
   2. Irreparable rotator cuff tear
   3. Rotator cuff tear arthropathy
   4. Severe osteoarthritis and rotator cuff deficiency or stiff shoulder
   5. Significant glenoid or socket side bone deformed or loss
   6. Reoccurrence of instability or a chronic shoulder dislocation
   7. Any other medical reason that the investigator determine that subject is a good candidate for a reverse total shoulder arthroplasty

Exclusion Criteria:

1. BMI \> 40 kg/m2
2. Previous contralateral shoulder surgery within 3 months of enrollment or that requires active treatment (i.e. surgery or brace)
3. Had surgery in the targeted shoulder within last 12 months of enrollment, except diagnostic arthroscopy without procedures
4. Had surgery in lower limbs (such as hip or knee) within last 6 months of enrollment
5. Corticosteroid injections in the ipsilateral shoulder within 3 months of enrollment
6. Complete deltoid muscle insufficiency
7. Glenoid retroversion great than 25 degrees based off a 2D axial CT scan
8. History of/or signs and/or symptoms of local or systemic infection including but not limited to septicemia; osteomyelitis
9. Neurologically confirmed nerve lesion compromising shoulder joint function
10. Poor meta-epiphyseal bone stock compromising stability of the implant including but not limited to humeral head fracture, iatrogenic glenoid fracture, severe osteoporosis
11. Metabolic disorders which may impair fixation and stability of the implant including but not limited to uncontrolled diabetes mellitus with an HbA1C \> 7.5%
12. Extended bone loss after previous surgery defined as: complete bone loss of greater and lesser tuberosity
13. Meta-epiphyseal bony defect (including large cyst)

Where it's running

  • Levy Shoulder Center
    Boca Raton, Florida, United States
    Recruiting
  • AdventHealth
    Orlando, Florida, United States
    Recruiting
  • Foundation for Orthopaedic Research and Education
    Tampa, Florida, United States
    Recruiting
  • Central Indiana Orthopedics
    Fishers, Indiana, United States
    Recruiting
  • Upstate Orthopedics
    East Syracuse, New York, United States
    Recruiting
  • Rothman Orthopaedic
    Philadelphia, Pennsylvania, United States
    Recruiting
Show 7 more locations
  • Guthrie
    Sayre, Pennsylvania, United States
    Recruiting
  • Cedars-Sinai Kerlan-Jobe Institute
    Los Angeles, California, United States
    Withdrawn
  • Western Orthopaedics
    Denver, Colorado, United States
    Completed
  • Rush Orthopaedics
    Chicago, Illinois, United States
    Completed
  • Duke University
    Durham, North Carolina, United States
    Completed
  • University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Withdrawn
  • University of Texas- Health Science Center
    San Antonio, Texas, United States
    Withdrawn

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.